Nasdaq Ppbt News Today

HC Wainwright reaffirmed their buy rating on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a research note published on Friday morning, Benzinga reports. They currently have a $10.00 price objective on the stock. Purple Biotech Price Performance Shares of Purple Biotech stock opened at $0.51 on Friday. The firm has a market cap […]

Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 418,100 shares, a decrease of 7.7% from the January 15th total of 452,800 shares. Based on an average trading volume of 80,300 shares, […]

Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) shares traded up 3.2% during trading on Wednesday . The stock traded as high as $0.82 and last traded at $0.80. 84,212 shares changed hands during mid-day trading, a decline of 9% from the average session volume of 92,756 shares. The stock had previously closed at $0.77. […]

Initial Activity in Head and Neck Cancer Demonstrated in NT219 Phase 1/2 Dose Escalation Study Patients’ Enrollment in the Phase 2 Randomized CM24...

REHOVOT, Israel, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company...

Financial results represent clinical trials progress with recruitment at a pace faster than expected in CM24 Phase 2 studyClinical data from both studies...

Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 787,900 shares, a growth of 17.2% from the June 30th total of 672,100 shares. Based on an average trading volume of 70,300 shares, the short-interest ratio […]

Jonestrading began coverage on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm issued a buy rating and a $8.00 price objective on the stock. Separately, Chardan Capital reiterated a buy rating on shares of Purple Biotech in a report on Monday, July 10th. Purple […]

Purple Biotech (NASDAQ:PPBT – Get Rating) and Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Purple Biotech and Rigel Pharmaceuticals’ […]

Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. ...